Endpoints News 生物医药· Shelby Livingston·· 10 天前AI 评分25
多个团队与 FDA 就临床 AI 工具初步交流
How early efforts to build autonomous clinical AI tools are approaching regulation
AI 导读
多个参与 ARPA-H Advocate 计划的团队已与 FDA 进行初步信息交流,距离临床 AI 工具项目启动不到两个月。
正文
Multiple teams participating in ARPA-H’s Advocate program have already had an initial informational meeting with the FDA, less than two months after the clinical AI …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news